title: [Guidelines for percutaneous coronary interventions].
authors.forename: Sigmund
authors.initials: S
authors.lastname: Silber
authors.forename: Per
authors.initials: P
authors.lastname: Albertsson
authors.forename: Francisco F
authors.initials: FF
authors.lastname: Avilés
authors.forename: Paolo G
authors.initials: PG
authors.lastname: Camici
authors.forename: Antonio
authors.initials: A
authors.lastname: Colombo
authors.forename: Christian
authors.initials: C
authors.lastname: Hamm
authors.forename: Erik
authors.initials: E
authors.lastname: Jørgensen
authors.forename: Jean
authors.initials: J
authors.lastname: Marco
authors.forename: Jan-Erik
authors.initials: JE
authors.lastname: Nordrehaug
authors.forename: Witold
authors.initials: W
authors.lastname: Ruzyllo
authors.forename: Philip
authors.initials: P
authors.lastname: Urban
authors.forename: Gregg W
authors.initials: GW
authors.lastname: Stone
authors.forename: William
authors.initials: W
authors.lastname: Wijns
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000379:methods* / Q000592:standards; D000925:Anticoagulants / Q000627:therapeutic use; D001918:Brachytherapy / Q000379:methods; D003327:Coronary Disease / Q000628:therapy*; D023903:Coronary Restenosis / Q000517:prevention & control; D004359:Drug Therapy, Combination; D005060:Europe; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D009204:Myocardial Revascularization / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D018570:Risk Assessment; D015607:Stents; D014336:Troponin / Q000097:blood
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014336:Troponin